Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-01-09 Sale |
2024-02-15 4:33 pm |
Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR Director |
13,037 | $0.5711 | $7,445 | 148,498 (Direct) |
View |
| 2024-01-03 Sale |
2024-01-05 5:54 pm |
Homology Medicines Inc. | FIXX | Alloway Paul See Remarks |
7,280 | $0.566 | $4,120 | 28,036 (Direct) |
View |
| 2024-01-03 Sale |
2024-01-05 5:49 pm |
Homology Medicines Inc. | FIXX | Michaud Charles Jr See Remarks |
1,708 | $0.571 | $975 | 11,598 (Direct) |
View |
| 2023-09-06 Sale |
2023-09-08 4:44 pm |
Homology Medicines Inc. | FIXX | Seymour Albert See Remarks |
1,448 | $1.1502 | $1,665 | 160,254 (Direct) |
View |
| 2023-08-03 Sale |
2023-08-07 9:39 pm |
Homology Medicines Inc. | FIXX | Jordan Julie Chief Medical Officer |
1,853 | $1.39 | $2,576 | 7,496 (Direct) |
View |
| 2023-08-02 Sale |
2023-08-04 4:08 pm |
Homology Medicines Inc. | FIXX | Jordan Julie Chief Medical Officer |
99 | $1.31 | $130 | 2,770 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-06 4:05 pm |
Homology Medicines Inc. | FIXX | Alloway Paul See Remarks |
10,965 | $1.4467 | $15,863 | 16,706 (Direct) |
View |
| 2023-01-09 Sale |
2023-01-11 4:05 pm |
Homology Medicines Inc. | FIXX | Blum Michael Lee Chief Commercial Officer |
2,454 | $1.3904 | $3,412 | 13,538 (Direct) |
View |
| 2023-01-09 Sale |
2023-01-11 4:05 pm |
Homology Medicines Inc. | FIXX | Alloway Paul See Remarks |
3,090 | $1.3903 | $4,296 | 20,103 (Direct) |
View |
| 2023-01-09 Sale |
2023-01-11 4:05 pm |
Homology Medicines Inc. | FIXX | Smith W Bradford See Remarks |
3,729 | $1.3912 | $5,188 | 14,219 (Direct) |
View |
| 2023-01-09 Sale |
2023-01-11 4:05 pm |
Homology Medicines Inc. | FIXX | Seymour Albert See Remarks |
3,620 | $1.3904 | $5,033 | 143,166 (Direct) |
View |
| 2023-01-09 Sale |
2023-01-11 4:05 pm |
Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR Director |
10,616 | $1.3905 | $14,762 | 108,395 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2024-03-27 5:17 pm |
N/A N/A |
Q32 Bio Inc. | QTTB | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC Director 10% Owner |
0 | $0 | 2,252,987 (Indirect) |
View |
Ownership |
2024-03-27 5:16 pm |
N/A 2031-01-21 |
Q32 Bio Inc. | QTTB | Iwicki Mark T Director |
0 | $0 | 44,837 (Direct) |
View |
Ownership |
2024-03-27 5:16 pm |
N/A N/A |
Q32 Bio Inc. | QTTB | Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Opportunity Fund II L.P. Atlas Venture Associates Opportunity II LP Atlas Venture Associates Opportunity II LLC 10% Owner |
0 | $0 | 2,092,106 (Direct) |
View |
Ownership |
2024-03-27 5:14 pm |
N/A N/A |
Q32 Bio Inc. | QTTB | Lundberg Sven Ante Director |
0 | $0 | 12,331 (Direct) |
View |
| 2024-03-25 Exercise |
2024-03-27 4:15 pm |
N/A N/A |
Q32 Bio Inc. | FIXX | Alloway Paul See Remarks |
47,060 | $0 | 51,566 (Direct) |
View |
| 2024-03-25 Exercise |
2024-03-27 4:15 pm |
N/A N/A |
Q32 Bio Inc. | FIXX | Michaud Charles Jr See Remarks |
12,896 | $0 | 18,046 (Direct) |
View |
| 2024-01-01 Exercise |
2024-02-15 4:33 pm |
N/A N/A |
Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR Director |
33,420 | $0 | 148,498 (Direct) |
View |
| 2024-01-01 Exercise |
2024-01-03 4:15 pm |
N/A N/A |
Homology Medicines Inc. | FIXX | Alloway Paul See Remarks |
18,610 | $0 | 58,846 (Direct) |
View |
| 2024-01-01 Exercise |
2024-01-03 4:15 pm |
N/A N/A |
Homology Medicines Inc. | FIXX | Michaud Charles Jr See Remarks |
4,240 | $0 | 19,754 (Direct) |
View |
Ownership(A) |
2023-12-11 4:15 pm |
N/A N/A |
Homology Medicines Inc. | FIXX | Michaud Charles Jr See Remarks |
0 | $0 | 9,066 (Direct) |
View |
Ownership |
2023-11-17 4:05 pm |
N/A N/A |
Homology Medicines Inc. | FIXX | Michaud Charles Jr See Remarks |
0 | $0 | 115,900 (Direct) |
View |
| 2023-09-06 Exercise |
2023-09-08 4:44 pm |
N/A N/A |
Homology Medicines Inc. | FIXX | Seymour Albert See Remarks |
4,620 | $0 | 160,254 (Direct) |
View |
| 2023-08-03 Exercise |
2023-08-07 9:39 pm |
N/A N/A |
Homology Medicines Inc. | FIXX | Jordan Julie Chief Medical Officer |
6,579 | $0 | 7,496 (Direct) |
View |
| 2023-08-02 Exercise |
2023-08-04 4:08 pm |
N/A N/A |
Homology Medicines Inc. | FIXX | Jordan Julie Chief Medical Officer |
350 | $0 | 2,770 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-15 7:25 pm |
N/A 2023-06-14 |
Homology Medicines Inc. | FIXX | GILLIS STEVEN Director |
23,000 | $0 | 23,000 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-15 6:33 pm |
N/A 2033-06-14 |
Homology Medicines Inc. | FIXX | Patterson Matthew R Director |
23,000 | $0 | 23,000 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-15 6:17 pm |
N/A 2033-06-14 |
Homology Medicines Inc. | FIXX | Thistle Mary Director |
23,000 | $0 | 23,000 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-15 6:14 pm |
N/A 2033-06-14 |
Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR Director |
23,000 | $0 | 23,000 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-15 6:09 pm |
N/A 2033-06-14 |
Homology Medicines Inc. | FIXX | Poulton Jeffrey V. Director |
23,000 | $0 | 23,000 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-15 6:04 pm |
N/A 2033-06-14 |
Homology Medicines Inc. | FIXX | REICIN ALISE Director |
23,000 | $0 | 23,000 (Direct) |
View |
Ownership |
2023-03-16 5:03 pm |
N/A N/A |
Homology Medicines Inc. | FIXX | Jordan Julie Chief Medical Officer |
0 | $0 | 306,569 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 4:05 pm |
N/A 2033-02-23 |
Homology Medicines Inc. | FIXX | Alloway Paul See Remarks |
191,000 | $0 | 191,000 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 4:05 pm |
N/A 2033-02-23 |
Homology Medicines Inc. | FIXX | Blum Michael Lee Chief Commercial Officer |
121,000 | $0 | 121,000 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 4:05 pm |
N/A 2033-02-23 |
Homology Medicines Inc. | FIXX | Smith W Bradford See remarks |
249,000 | $0 | 249,000 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 4:05 pm |
N/A 2033-02-23 |
Homology Medicines Inc. | FIXX | Seymour Albert See Remarks |
737,000 | $0 | 737,000 (Direct) |
View |
Ownership(A) |
2023-01-20 4:05 pm |
N/A N/A |
Homology Medicines Inc. | FIXX | Blum Michael Lee Chief Commercial Officer |
0 | $0 | 3,280 (Direct) |
View |
| 2023-01-01 Exercise |
2023-01-04 4:37 pm |
N/A N/A |
Homology Medicines Inc. | FIXX | Blum Michael Lee Chief Commercial Officer |
7,590 | $0 | 28,762 (Direct) |
View |
| 2023-01-01 Exercise |
2023-01-04 4:36 pm |
N/A N/A |
Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR Director |
33,000 | $0 | 172,151 (Direct) |
View |
| 2023-01-01 Exercise |
2023-01-04 4:35 pm |
N/A N/A |
Homology Medicines Inc. | FIXX | Seymour Albert See Remarks |
11,220 | $0 | 165,276 (Direct) |
View |